Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1997
11/18/1997US5688688 Vector for expression of a polypeptide in a mammalian cell
11/18/1997US5688681 Monoclonal antibodies to human leukemia inhibitory factor
11/18/1997US5688678 Induce bone formation; wound healing agents
11/18/1997US5688677 Administering dna for treatment of cystic fibrosis with transmembrane conductance controllers
11/18/1997US5688665 Binding to cyclin dependent kinases; controlling cell reproduction
11/18/1997US5688664 Oligopeptides, polypeptides and sequences
11/18/1997US5688657 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
11/18/1997US5688651 Antiagglomerants, monoclonal antibodies, genetic engineered antibody antigens binding fragments and target polypeptides formed by denaturing target polypeptides, mixing, incubation and testing
11/18/1997US5688641 Breast cancer
11/18/1997US5688530 Acromegaly; breast cancer
11/18/1997US5688526 Oxidation resistance
11/18/1997US5688525 Pharmaceutical formulation and process
11/18/1997US5688511 Cellular protein TDP-43 and regulation of HIV-1 gene expression
11/18/1997US5688507 Cardiovascular disorders such as treatment of angina, heart attack, stroke and as anticoagulants
11/18/1997US5688505 Method for treating cancer with monoclonal antibodies to oncofetal protein
11/18/1997US5688504 Antagonists
11/18/1997US5688503 Modification of plasminogen activators
11/18/1997US5688502 Digestive enzyme immobilized in gel matrix
11/18/1997US5688499 Antagonism of endothelin actions
11/13/1997WO1997042501A1 Phosphotyrosine mimics and methods for identifying and using same
11/13/1997WO1997042340A1 Ob receptor isoforms and nucleic acids encoding them
11/13/1997WO1997042329A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
11/13/1997WO1997042325A1 B. burgdorferi polypeptides expressed in vivo
11/13/1997WO1997042324A1 Use of interleukin-10 to produce a population of suppressor cells
11/13/1997WO1997042322A1 Glycoprotein hormone superagonists
11/13/1997WO1997042321A1 Osteoclast transporter protein
11/13/1997WO1997042319A1 NOVEL Fas ANTIGEN DERIVATIVES
11/13/1997WO1997042318A1 Vaccines
11/13/1997WO1997042317A1 APTAMERS FOR COMPLEMENT PROTEIN C3b
11/13/1997WO1997042313A1 Transgenic plants expressing assembled secretory antibodies
11/13/1997WO1997042309A1 TRANSGENIC ANIMALS DEFICIENT IN ENDOGENOUS β3-ADRENERGIC RECEPTOR AND USES THEREOF
11/13/1997WO1997042224A1 Neurotactin and uses therefor
11/13/1997WO1997042223A1 hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY
11/13/1997WO1997042222A1 Methods and means for inhibition of cdk4 activity
11/13/1997WO1997042219A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR
11/13/1997WO1997042218A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
11/13/1997WO1997042217A1 Radiolabeled fusion toxins for cancer therapy
11/13/1997WO1997042213A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
11/13/1997WO1997042212A1 Sok-1 and methods of use
11/13/1997WO1997042211A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor
11/13/1997WO1997042209A1 Human rad
11/13/1997WO1997041899A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
11/13/1997WO1997041898A1 Targeted combination immunotherapy of cancer
11/13/1997WO1997041895A2 TREATMENT OF ASTHMA WITH TNFR-Ig
11/13/1997WO1997041887A1 Treatment of partial growth hormone insensitivity syndrome
11/13/1997WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997WO1997041885A1 Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets
11/13/1997WO1997041884A1 Method of treatment
11/13/1997WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997WO1997041882A1 Method for treating inflammation
11/13/1997WO1997041881A1 Morphogen treatment for chronic renal failure
11/13/1997WO1997041880A1 Therapies for chronic renal failure
11/13/1997WO1997041879A1 Enhancement of sleep with a growth hormone secretagogue
11/13/1997WO1997041878A1 Treatment of mood disorders with a growth hormone secretagogue
11/13/1997WO1997041863A1 Mixed chimerism and tolerance
11/13/1997WO1997041854A1 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same
11/13/1997WO1997041849A1 Anti-viral method
11/13/1997WO1997041833A1 Dispersible macromolecule compositions and methods for their preparation and use
11/13/1997WO1997041831A1 Stimulation of immune response with low doses of il-2
11/13/1997WO1997041824A2 Antiangiogenic peptides derived from plasminogen
11/13/1997WO1997037998A3 Neuropeptide y receptor y5 and nucleic acid sequence
11/13/1997WO1997033996A3 Human bikunin
11/13/1997WO1997032607A3 Activated linkers and methods for making and purifying the same
11/13/1997WO1997032020A3 Shc proteins
11/13/1997WO1997031611A3 Treatment of begnin prostatic hyperplasia
11/13/1997WO1997029195A3 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
11/13/1997WO1997025032A3 Monoglyceride compositions and their use against helicobacter
11/13/1997WO1996040048A3 Novel uses for thyroid hormones or thyroid hormone-like compounds
11/13/1997DE19618797A1 Vehikel zum Transport molekularer Substanz Vehicle for the transport of molecular substance
11/13/1997CA2253971A1 Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions
11/13/1997CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997CA2253904A1 Targeted combination immunotherapy of cancer
11/13/1997CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997CA2253864A1 Neurotactin and uses therefor
11/13/1997CA2253834A1 B. burgdorferi polypeptides expressed in vivo
11/13/1997CA2253832A1 Ob receptor isoforms and nucleic acids encoding them
11/13/1997CA2253803A1 Use of interleukin-10 to produce a population of suppressor cells
11/13/1997CA2253776A1 Phosphotyrosine mimics and methods for identifying and using same
11/13/1997CA2253743A1 Anti-viral method
11/13/1997CA2253597A1 Mixed chimerism and tolerance
11/13/1997CA2253557A1 Treatment of asthma with tnfr-ig
11/13/1997CA2253494A1 Novel fas antigen derivative
11/13/1997CA2253454A1 Transgenic plants expressing assembled secretory antibodies
11/13/1997CA2253441A1 Glycoprotein hormone superagonists
11/13/1997CA2253390A1 Enhancement of sleep with a growth hormone secretagogue
11/13/1997CA2253312A1 Method for treating inflammation
11/13/1997CA2251129A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
11/13/1997CA2250579A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
11/12/1997EP0806477A1 Recombinant dna prepared by integrating dna that codes for myosin heavy-chain sm1 isoform protein into vector dna, and microorganism and arteriosclerosis remedy both containing the recombinant dna
11/12/1997EP0806432A1 Glutathione monoester sulfonate
11/12/1997EP0806203A2 Anti-viral compositions
11/12/1997EP0805871A1 Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen
11/12/1997EP0805869A2 Direct gene transfer into the ruminant mammary gland
11/12/1997EP0805863A2 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN ahpCF OPERON
11/12/1997EP0805862A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
11/12/1997EP0805859A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
11/12/1997EP0805858A2 Inhibition of neovascularization using vegf-specific oligonucleotides
11/12/1997EP0805853A1 Lineage-directed induction of human mesenchymal stem cell differentiation
11/12/1997EP0805822A1 Spray dried erythropoietin
11/12/1997EP0805820A1 Ligands for eph-like receptors